Young Li
Stock Analyst at Jefferies
(0.62)
# 3,166
Out of 5,045 analysts
7
Total ratings
50%
Success rate
-18.82%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Initiates: Buy | $145 | $135.79 | +6.78% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $8.59 | +4.77% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $70.11 | +64.03% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.11 | +12.61% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $30.69 | +95.50% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $9.78 | +370.35% | 1 | Jul 16, 2021 |
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $135.79
Upside: +6.78%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $8.59
Upside: +4.77%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $70.11
Upside: +64.03%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.11
Upside: +12.61%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $30.69
Upside: +95.50%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $9.78
Upside: +370.35%